Skip to main content

Table 2 Relationships between prognosis-related metabolic genes and clinicopathologic parameters

From: Identification and validation of an individualized metabolic prognostic signature for predicting the biochemical recurrence of prostate cancer based on the immune microenvironment

Gene

 

Age

Gleason

T stage

N stage

Title 4

 ≤ 65

 > 65

6−7 (3 + 4)

7 (4 + 3)−10

T1-T2

T3-T4

N0

N1

N

 

297

115

158

254

318

92

293

67

Data

CEL

t

0.274

1.649

0.555

0.268

Data

P

0.784

0.100

0.579

0.789

Data

PDE6G

t

1.963

4.171

0.201

2.950

Data

P

0.050

 < 0.001

0.841

0.003

Data

CYP3A4

t

0.134

2.476

0.231

0.868

Data

P

0.893

0.014

0.817

0.386

Data